Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001411690-25-000069
Filing Date
2025-06-12
Accepted
2025-06-12 16:50:58
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749761452.html 4  
1 FORM 4 wk-form4_1749761452.xml 4 4172
  Complete submission text file 0001411690-25-000069.txt   5965
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Issuer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK NY 10011
Business Address
Vuori Kristiina MD (Reporting) CIK: 0001612627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38613 | Film No.: 251043589